Epinephrine, also known as adrenaline, is both an endogenous hormone and a synthetic compound. It is produced in the adrenal medulla, a part of the adrenal glands, and belongs to the catecholamine chemical class. As a hormone and neurotransmitter, epinephrine plays a crucial role in the body's fight-or-flight response. Researchers have extensively studied its effects on cardiovascular and respiratory systems, as well as its role in metabolic processes. Epinephrine is primarily involved in increasing heart rate, contracting blood vessels, and dilating air passages. It is a key focus in research areas such as anaphylaxis, cardiac arrest, and asthma management. The mechanism of action of epinephrine involves its interaction with adrenergic receptors, specifically alpha and beta receptors. Upon binding to these receptors, it activates a cascade of intracellular events, including the activation of adenylate cyclase and increased cyclic AMP levels, leading to physiological responses such as increased cardiac output and bronchodilation. Pharmacokinetically, epinephrine has a short half-life, with intravenous administration resulting in a half-life of approximately 2-3 minutes due to rapid metabolism by the liver and other tissues. Its bioavailability varies significantly with the route of administration, being poor when taken orally due to extensive first-pass metabolism. Clinically, epinephrine is used in emergency situations such as anaphylactic shock and cardiac arrest. It is available in various formulations, including auto-injectors like EpiPen. Regulatory agencies worldwide have approved its use, with specific guidelines for administration and storage.